These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 38615878)
1. Outcomes of ventricular tachycardia ablation in patients with ischemic and non-ischemic cardiomyopathy: A propensity-score matched analysis. Gomes DA; Sousa Paiva M; Matos D; Bello AR; Rodrigues G; Carmo J; Ferreira J; Moscoso Costa F; Galvão Santos P; Carmo P; Cavaco D; Bello Morgado F; Adragão P Rev Port Cardiol; 2024 Jun; 43(6):341-349. PubMed ID: 38615878 [TBL] [Abstract][Full Text] [Related]
2. Beyond the Storm: Comparison of Clinical Factors, Arrhythmogenic Substrate, and Catheter Ablation Outcomes in Structural Heart Disease Patients With versus Those Without a History of Ventricular Tachycardia Storm. Kumar S; Fujii A; Kapur S; Romero J; Mehta NK; Tanigawa S; Epstein LM; Koplan BA; Michaud GF; John RM; Stevenson WG; Tedrow UB J Cardiovasc Electrophysiol; 2017 Jan; 28(1):56-67. PubMed ID: 27781325 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of a combined vs non-combined endo-epicardial ventricular tachycardia ablation strategy. Matos D; Adragão P; Pisani C; Hatanaka V; Freitas P; Costa F; Chokr M; Hardy C; Ferreira AM; Carmo P; Laura S; Morgado F; Cavaco D; Mendes M; Scanavacca M J Interv Card Electrophysiol; 2023 Jan; 66(1):87-94. PubMed ID: 35258753 [TBL] [Abstract][Full Text] [Related]
4. Catheter Ablation for Ventricular Tachycardia in Ischaemic Versus Non-Ischaemic Cardiomyopathy: A Systematic Review and Meta-Analysis. Kanagaratnam A; Virk SA; Pham T; Anderson RD; Turnbull S; Campbell T; Bennett R; Thomas SP; Lee G; Kumar S Heart Lung Circ; 2022 Aug; 31(8):1064-1074. PubMed ID: 35643798 [TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease. Kumar S; Romero J; Mehta NK; Fujii A; Kapur S; Baldinger SH; Barbhaiya CR; Koplan BA; John RM; Epstein LM; Michaud GF; Tedrow UB; Stevenson WG Heart Rhythm; 2016 Oct; 13(10):1957-63. PubMed ID: 27392945 [TBL] [Abstract][Full Text] [Related]
6. Endocardial substrate mapping for monomorphic ventricular tachycardia ablation in ischemic and non-ischemic cardiomyopathy. Fukuzawa K; Yoshida A; Kubo S; Takano T; Kiuchi K; Kanda G; Takami K; Kumagai H; Torii S; Takami M; Yokoyama M; Hirata K Kobe J Med Sci; 2008 Jul; 54(2):E122-35. PubMed ID: 18772614 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the arrhythmogenic substrate for ventricular tachycardia in patients with ischemic vs non-ischemic cardiomyopathy - insights from high-density, multi-electrode catheter mapping. Kotake Y; Nalliah CJ; Campbell T; Bennett RG; Turnbull S; Kumar S J Interv Card Electrophysiol; 2023 Jan; 66(1):5-14. PubMed ID: 34787768 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia. Nakahara S; Tung R; Ramirez RJ; Michowitz Y; Vaseghi M; Buch E; Gima J; Wiener I; Mahajan A; Boyle NG; Shivkumar K J Am Coll Cardiol; 2010 May; 55(21):2355-65. PubMed ID: 20488307 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of catheter ablation for ventricular tachycardia in ischemic cardiomyopathy patients without an ICD implantation. Li L; Ding L; Wu L; Zheng L; Zhou L; Zhang Z; Xiong Y; Zhang Z; Yao Y Heart Rhythm; 2024 Nov; 21(11):2148-2156. PubMed ID: 38734226 [TBL] [Abstract][Full Text] [Related]
10. Long-Term Outcomes of Catheter Ablation of Electrical Storm in Nonischemic Dilated Cardiomyopathy Compared With Ischemic Cardiomyopathy. Muser D; Liang JJ; Pathak RK; Magnani S; Castro SA; Hayashi T; Garcia FC; Supple GE; Riley MP; Lin D; Dixit S; Zado ES; Frankel DS; Callans DJ; Marchlinski FE; Santangeli P JACC Clin Electrophysiol; 2017 Jul; 3(7):767-778. PubMed ID: 29759543 [TBL] [Abstract][Full Text] [Related]
11. Outcomes of Catheter Ablation of Ventricular Tachycardia Based on Etiology in Nonischemic Heart Disease: An International Ventricular Tachycardia Ablation Center Collaborative Study. Vaseghi M; Hu TY; Tung R; Vergara P; Frankel DS; Di Biase L; Tedrow UB; Gornbein JA; Yu R; Mathuria N; Nakahara S; Tzou WS; Sauer WH; Burkhardt JD; Tholakanahalli VN; Dickfeld TM; Weiss JP; Bunch TJ; Reddy M; Callans DJ; Lakkireddy DR; Natale A; Marchlinski FE; Stevenson WG; Della Bella P; Shivkumar K JACC Clin Electrophysiol; 2018 Sep; 4(9):1141-1150. PubMed ID: 30236386 [TBL] [Abstract][Full Text] [Related]
12. Can ventricular tachycardia non-inducibility after ablation predict reduced ventricular tachycardia recurrence and mortality in patients with non-ischemic cardiomyopathy? A meta-analysis of twenty-four observational studies. Hu J; Zeng S; Zhou Q; Zhu W; Xu Z; Yu J; Hong K Int J Cardiol; 2016 Nov; 222():689-695. PubMed ID: 27521538 [TBL] [Abstract][Full Text] [Related]
13. Relevance of Chronic Total Occlusion for Outcome of Ventricular Tachycardia Ablation in Ischemic Cardiomyopathy. Lurz JA; Schmidt E; Kresoja KP; Torri F; König S; Darma A; Arya A; Bertagnolli L; Hindricks G; Dinov B J Interv Cardiol; 2022; 2022():6829725. PubMed ID: 35935125 [TBL] [Abstract][Full Text] [Related]
14. Complication rates following ventricular tachycardia ablation in ischaemic and non-ischaemic cardiomyopathies: a systematic review. Ding WY; Pearman CM; Bonnett L; Adlan A; Chin SH; Denham N; Modi S; Todd D; Hall MCS; Mahida S J Interv Card Electrophysiol; 2022 Jan; 63(1):59-67. PubMed ID: 33512605 [TBL] [Abstract][Full Text] [Related]
15. Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial. Di Biase L; Burkhardt JD; Lakkireddy D; Carbucicchio C; Mohanty S; Mohanty P; Trivedi C; Santangeli P; Bai R; Forleo G; Horton R; Bailey S; Sanchez J; Al-Ahmad A; Hranitzky P; Gallinghouse GJ; Pelargonio G; Hongo RH; Beheiry S; Hao SC; Reddy M; Rossillo A; Themistoclakis S; Dello Russo A; Casella M; Tondo C; Natale A J Am Coll Cardiol; 2015 Dec; 66(25):2872-2882. PubMed ID: 26718674 [TBL] [Abstract][Full Text] [Related]
16. Prediction and prognosis of ventricular tachycardia recurrence after catheter ablation with remote magnetic navigation for electrical storm in patients with ischemic cardiomyopathy. Jin Q; Jacobsen PK; Pehrson S; Chen X Clin Cardiol; 2017 Nov; 40(11):1083-1089. PubMed ID: 28817194 [TBL] [Abstract][Full Text] [Related]
17. Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy with near-normal left ventricular ejection fraction. Bennett RG; Campbell T; Kotake Y; Turnbull S; Kumar S Heart Rhythm; 2022 Jan; 19(1):51-60. PubMed ID: 34597769 [TBL] [Abstract][Full Text] [Related]
18. Catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: Impact of concomitant amiodarone therapy on short- and long-term clinical outcomes. Di Biase L; Romero J; Du X; Mohanty S; Trivedi C; Della Rocca DG; Patel K; Sanchez J; Yang R; Alviz I; Mohanty P; Gianni C; Tarantino N; Zhang XD; Horton R; Al-Ahmad A; Lakkireddy D; Burkhardt DJ; Chen M; Natale A Heart Rhythm; 2021 Jun; 18(6):885-893. PubMed ID: 33592323 [TBL] [Abstract][Full Text] [Related]